Is It An Open Goal For Germany’s New Cannabis Medicine?
The imminent launch of the first new European cannabis-based pharmaceutical for over five years could not have been…
VERTANICAL Receives First European Marketing Authorization for Exilby® as a First-in-Class Non-Opioid Treatment for Chronic Low Back Pain
GRÄFELFING, Germany, June 9, 2026 /PRNewswire/ — VERTANICAL today announced that Exilby® (VER-01) has received marketing authorization in…